As previously described, HDACi-related apoptosis induction in CML cells could be enhanced by imatinib-mediated downregulation of anti-apoptotic MCL-1 expression, which was upregulated by MAKV-8 [40]. The gene discussed is MCL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.